GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » Research & Development

Tiziana Life Sciences (Tiziana Life Sciences) Research & Development : $8.11 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Tiziana Life Sciences's Research & Development for the six months ended in Dec. 2023 was $4.83 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $8.11 Mil.


Tiziana Life Sciences Research & Development Historical Data

The historical data trend for Tiziana Life Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences Research & Development Chart

Tiziana Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.71 5.99 13.21 12.96 8.11

Tiziana Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.62 7.46 5.49 3.29 4.83

Tiziana Life Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $8.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tiziana Life Sciences  (NAS:TLSA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Tiziana Life Sciences Research & Development Related Terms

Thank you for viewing the detailed overview of Tiziana Life Sciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Tiziana Life Sciences (Tiziana Life Sciences) Business Description

Traded in Other Exchanges
Address
2 Church Street, Clarendon House, Hamilton, BMU, HM 11
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.

Tiziana Life Sciences (Tiziana Life Sciences) Headlines

From GuruFocus